Item 7. Management’s Discussion and Analysis
Item
7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
This
information should be read in conjunction with the financial statements and notes included in Item 15 of Part IV of this annual report
on Form 10-K (this “Form 10-K”). This Form 10-K contains “forward-looking statements” within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Exchange Act, and such forward-looking statements involve risks and uncertainties.
All statements (other than statements of historical fact) included in this Form 10-K that address activities, events or developments
that may occur in the future, the Trust’s operations, the Sponsor’s plans and references to the Trust’s future success
and other similar matters are forward-looking statements. Words such as “could,” “would,” “may,”
“expect,” “intend,” “estimate,” “predict,” and variations on such words or negatives
thereof, and similar expressions that reflect our current views with respect to future events and Trust performance, are intended to
identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties that
are difficult to predict and many of which are outside of our control, and actual results could differ materially from those discussed.
Forward-looking statements involve risks and uncertainties that could cause actual results or outcomes to differ materially from those
expressed therein. We express our estimates, expectations, beliefs, and projections in good faith and believe them to have a reasonable
basis. However, we make no assurances that management’s estimates, expectations, beliefs, or projections will be achieved or accomplished.
These forward-looking statements are based on assumptions about many important factors that could cause actual results to differ materially
from those in the forward-looking statements. We do not intend to update any forward-looking statements even if new information becomes
available or other events occur in the future, except as required by the federal securities laws.
Organization
and Trust Overview
The
Trust is a Delaware statutory trust, formed on June 3, 2024, pursuant to the DSTA. The Trust operates pursuant to the Trust Agreement.
The Trust is not registered as an investment company under the 1940 Act and is not a commodity pool for purposes of the CEA. The Trust
is managed and controlled by the Sponsor. The Sponsor is a limited liability company formed in the state of Delaware on June 16, 2021,
and is a wholly owned subsidiary of 21co Holdings Limited (formerly known as Amun Holdings Limited). The ultimate parent company of 21co
Holdings Limited is FalconX. The Sponsor is not subject to regulation by the CFTC as a commodity pool operator with respect to the Trust,
or a commodity trading advisor with respect to the Trust. The Trust is an exchange-traded fund that issues common shares of beneficial
interest representing fractional undivided beneficial interests in its net assets that trade on the Exchange. The Shares are listed for
trading on the Exchange under the ticker symbol “TSOL”.
The
Sponsor served as the “Seed Capital Investor” to the Trust. On September 17, 2025, the Sponsor, in its capacity as Seed Capital
Investor, subject to conditions, purchased the Initial Seed Shares at a per-Share price of $50.00. Total proceeds to the Trust from the
sale of the Initial Seed Shares were $100. Delivery of the Initial Seed Shares was made on September 17, 2025.
The
Trust’s investment objective is to seek to track the performance of SOL, as measured by the performance of the Pricing Benchmark,
adjusted for the Trust’s expenses and other liabilities, and to reflect rewards from staking a portion of the Trust’s SOL,
to the extent the Sponsor in its sole discretion determines that the Trust may do so without undue legal or regulatory risk, such as,
without limitation, the risk of jeopardizing the Trust’s ability to qualify as a grantor trust for U.S. Federal income tax purposes.
CF Benchmarks Ltd. is the Pricing Benchmark Provider. The Pricing Benchmark is designed to reflect the performance of SOL in U.S. dollars.
In seeking to achieve its investment objective, the Trust holds SOL at its Custodians and values its Shares daily based on the Pricing
Benchmark. The Trust is a passive investment vehicle and is not a leveraged product. The Sponsor does not actively manage the SOL held
by the Trust.
The
Trust issues Shares only in Creation Baskets of 10,000 or multiples thereof. Creation Baskets are issued and redeemed in exchange for
cash or for SOL. Individual Shares will not be redeemed by the Trust but are listed and traded on the Exchange under the ticker symbol
“TSOL.” The Trust issues Shares in Creation Baskets on a continuous basis at the applicable NAV per Share on the creation
order date.
The Trust pays the unitary
Sponsor Fee of 0.21% of the Trust’s NAV. The Sponsor Fee is paid by the Trust to the Sponsor as compensation for services performed
under the Trust Agreement. The Sponsor Fee accrues daily and is payable in SOL weekly in arrears. The Administrator calculates the Sponsor
Fee on a daily basis by applying a 0.21% annualized rate to the Trust’s NAV, and the amount of SOL payable in respect of each daily
accrual is determined by reference to the Pricing Benchmark. The Sponsor has agreed to pay all operating expenses (except for litigation
expenses and other extraordinary expenses) out of the Sponsor Fee. The Trust also pays 10% of the staking rewards generated by the Trust’s
Staking Activities after deduction of the Staking Provider Consideration to the Sponsor and retain the remainder.
69
The
Trust is an “emerging growth company” as that term is used in the Securities Act, and, as such, the Trust may elect to comply
with certain reduced public company reporting requirements.
The
NAV of the Trust is used by the Trust in its day-to-day operations to measure the net value of the Trust’s assets. The NAV is calculated
on each Business Day and is equal to the aggregate value of the Trust’s assets less its liabilities based on the Pricing Benchmark
price. In determining the NAV of the Trust on any Business Day, the Administrator calculates the price of the SOL held by the Trust as
of 4:00 p.m. ET on such day. The Administrator also calculates the “NAV per Share” of the Trust, which equals the NAV of
the Trust divided by the number of outstanding Shares.
In
addition to calculating NAV and NAV per Share, for purposes of the Trust’s financial statements, the Trust determines the Principal
Market NAV and Principal Market NAV per Share on each valuation date for such financial statements. The determination of the Principal
Market NAV and Principal Market NAV per Share is identical to the calculation of NAV and NAV per Share, respectively, except that the
value of SOL is determined using the fair value of SOL based on the price in the SOL market that the Trust considers its “principal
market” as of 4:00 p.m. ET on the valuation date, rather than using the Pricing Benchmark.
NAV
and NAV per Share are not measures calculated in accordance with GAAP and are not intended as substitutes for Principal Market and Principal
Market NAV per Share, respectively.
Critical
Accounting Estimates
The
financial statements and accompanying notes are prepared in accordance with GAAP. The preparation of these financial statements relies
on estimates and assumptions that impact the Trust’s financial position and results of operations. These estimates and assumptions
affect the Trust’s application of accounting policies. Below is a summary of accounting policies on cash and investment valuation.
There were no material estimates involving a significant level of estimation uncertainty that had or are reasonably likely to have had
a material impact on the Trust’s financial condition used in the preparation of the financial statements. In addition, please refer
to Note 2 to the Financial Statements included in this report for further discussion of the Trust’s accounting policies.
Cash
Cash
includes non-interest bearing, non-restricted cash maintained with one financial institution that does not exceed U.S. federally insured
limits.
Investment
Valuation
The
Trust’s policy is to value investments held at fair value. The Trust follows the provisions of ASC 820, Fair Value Measurements
(“ASC 820”). ASC 820 provides guidance for determining fair value and requires increased disclosure regarding the inputs
to valuation techniques used to measure fair value. ASC 820 determines fair value to be the price that would be received for SOL in a
current sale, which assumes an exit price resulting from an orderly transaction between market participants on the measurement date.
ASC 820-10 requires the assumption that SOL is sold in its principal market to market participants (or in the absence of a principal
market, the most advantageous market).
The
Trust utilizes an exchange traded price from the Trust’s principal market for SOL as of 4:00 p.m. ET on the Trust’s financial
statement measurement date.
Results
of Operations
For the period September
17, 2025 (date of initial seeding) through December 31, 2025*
The
Trust’s net asset value increased to $5,735,019 on December 31, 2025, primarily from an increase in the number of shares outstanding
of 460,000 from September 17, 2025 (date of initial seeding) to December 31, 2025.
70
Net
realized and change in unrealized loss on investment in SOL for the period September 17, 2025 (date of initial seeding) through December
31, 2025, was $4,323,701 which includes a net change in unrealized depreciation on investment in SOL of $748,004. Net realized and unrealized
loss on investment in SOL for the period was driven by SOL price depreciation throughout the year to $123.97 per SOL as of December 31,
2025. Net decrease in net assets resulting from operations was $4,147,646 for the year ended December 31, 2025, which consisted of a
net increase in the number of shares outstanding and by the aforementioned net realized and change in unrealized loss on investment in
SOL.
*
No prior year comparative
period has been provided as this is the first year of the Trust’s operations.
Liquidity
and Capital Resources
The Trust is not aware of
any trends, demands, commitments, events, or uncertainties that are reasonably likely to result in material changes to its liquidity needs.
The Trust’s ordinary recurring expenses are the fee paid to the Sponsor at an annual rate of 0.21% of the Trust’s NAV and
10% of the staking rewards generated by the Trust’s Staking Activities after deduction of the Staking Provider Consideration to
the Sponsor and retain the remainder. In exchange for the Sponsor Fee, the Sponsor has agreed to assume the ordinary fees and expenses
incurred by the Trust, including but not limited to the following: fees charged by Administrator, the Custodians, Transfer Agent and the
Trustee, the Marketing Fee, the Exchange’s listing fees, typical maintenance and transaction fees of the DTC, SEC registration fees,
printing and mailing costs, website fees, tax reporting fees, audit fees, license fees and expenses, up to $100,000 per annum in ordinary
legal fees and expenses. The Sponsor bears expenses in connection with the Trust’s organization and initial offering costs.
The Sponsor is not required to pay any extraordinary or non-routine
expenses. Extraordinary expenses are fees and expenses which are unexpected or unusual in nature, such as legal claims and liabilities
and litigation costs or indemnification or other unanticipated expenses. Extraordinary fees and expenses also include material expenses
which are not currently anticipated obligations of the Trust. The Trust will be responsible for the payment of such expenses to the extent
any such expenses are incurred. Routine operational, administrative, and other ordinary expenses are not deemed extraordinary expenses.
The Trust will sell SOL on an as-needed basis to pay the Sponsor Fee.
Off-Balance
Sheet Arrangements
The
Trust does not have any off-balance sheet arrangements.
Item
7A. Quantitative and Qualitative Disclosures about Market Risks
We
are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise
required under this item.